The Science is Clear:
DynamiCare Works.
DynamiCare has collaborated with leading academic institutions to conduct clinical studies on DynamiCare, which have demonstrated a 2-4x increase in quit rates across drugs, alcohol, and tobacco.
DynamiCare builds on the existing research behind Contingency Management (CM), or motivational incentives, which promotes accountability and motivation through the use of positive reinforcement. It has been recommended by the NIH, U.S. Surgeon General, American Society of Addiction Medicine, and validated in over 100 randomized controlled trials. This methodology, and DynamiCare’s approach, has been covered in the New York Times.
DynamiCare wins $1M prize from Ohio in recognition of improved outcomes:
“A smartphone-smartcard platform for contingency management in an inner-city substance use disorder outpatient program” DeFulio et al, 2020.
ACCESS THE FULL PAPER: Journal of Substance Abuse Treatment
Download the white paper
“A Smartphone-Smartcard Platform for Implementing Contingency Management in Buprenorphine Maintenance Patients With Concurrent Stimulant Use Disorder” DeFulio et al, 2021.
ACCESS THE FULL PAPER: Frontiers in Psychiatry
“Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare health” Hammond et al, 2021.
ACCESS THE FULL PAPER: Journal of Substance Abuse Treatment
Read preliminary results
DynamiCare Receives FDA Breakthrough Status for Smoking Cesastion During Pregnancy:
“Smartphone-based financial incentives to promote smoking cessation during pregnancy: A pilot study” Kurti et al, 2020.
ACCESS THE FULL PAPER: Journal of Preventive Medicine
View Summary of Results
“Effect of Smartphone-Based Financial Incentives on Peripartum Smoking Among Pregnant Individuals: A Randomized Clinical Trial” Kurti et al, 2022.
ACCESS THE FULL PAPER: JAMA Network Open
“A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth” Palmer et al, 2022.
ACCESS THE FULL PAPER: Drug and Alcohol Dependence
DynamiCare + MAT
Confirmed Buprenorphine Adherence rate of 76% with DynamiCare
“Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence.” DeFulio et al, 2022.
ACCESS THE FULL PAPER: Behavior Analysis in Practice
“Implications of epidemic-pandemic convergence for routine care adoption of contingency management: A case study.” Regnier and DeFulio, 2022.
ACCESS THE FULL PAPER: Experimental and Clinical Psychopharmacology
Employer Case Study: Smoking Cessation
Quit Rate Increased from 4% to 28% with DynamiCare
“With our in-person program, most people didn’t complete it, and if they did, the only measure of success we had was whether they set a quit date. We had no idea how many people actually quit. With DynamiCare, we were not only able to boost the quit rate tremendously but also get solid data on quit rates to measure the effectiveness of the program.”
- Jeanie Foley RN, Project Manager at St. Elizabeth Healthcare